Login
Member Login
Member Login
About
About SMI
Board of Directors
SMI Staff
FAQs
SMI Antitrust Guidelines
Membership
About Membership
Member Eligibility
SMI Community
Tools
SMI Toolbox
Programs
About Programs
Advocacy Program
Advancing Women Leaders (AWL)
Tom Hughes Collaboration Award
Councils
About Councils
Clinical Integration
Key Strategic Collaboration
Supply Chain Community Impact
Intelligent Supply Chain
Events & Media
Events
Podcast
Press Releases
Clinical Integration Maturity Model – Trading Partner, Provider (selection 4)
Step
1
of
4
25%
Step 2:
Provider Individually
System-wide clinical integration if applicable
Provider Individually
Organization
Step 3:
From the options below, which level best represents your organization/service line/department/ OR program in providing patient care:
People
Level 4
Fully integrated and aligned incentives
Creating accountable small group of commercial & clinical leaders to have focused meetings with SC/MD leaders of the IDN to drive mutual value for both the organizations.
Level 3
Cross functional understanding of stakeholder needs and requirements. System-wide clinical integration if applicable
Suppliers aligned with providers from some type of risk component.
Level 2
Common language and communications
Suppliers share retrospective data; contracts based on spend alone.
Level 1
Beginning the Conversation
Reactive approach to supply management (e.g., need more inventory because demand planning data is not available). No risk sharing contracts, no tracking of usage performance
Step 4:
From the options below, which level best represents your organization/service line/department/ OR program in providing patient care:
Process
Level 4
Fully integrated and aligned incentives
Regular cadence of business review meetings with SC and MD leaders to understand IDN priorities and jointly discuss commercial and clinical models. Partners in business model innovation (BMI) to look beyond price and drive meaningful growth & achive contract compliance. Definded processes for clinical and commercial partnerships (e.g. outcomes protection programs/Value based programs), Executive engagement as nedded.
Level 3
Cross functional understanding of stakeholder needs and requirements. Clinical integration across company divisions
Some risk share arrangements may be in place; alignment with provider and physicians on product decisions and efficiencies (e.g., block schedules).
Level 2
Common language and communications
No/limited risk share agreements. Siloed approach in contraction with the providers for supplies / equipment. Some data available for demand planning from the provider (may be provided by provider or collected based on purchase history).
Level 1
Beginning the Conversation
Limited or no understanding of capital planning and supply forecasting across IDN. No risk sharing/ outcomes protection agreements. Only transactional approach in supplying products as per the provider demands.
Step 5:
From the options below, which level best represents your organization/service line/department/ OR program in providing patient care:
Technology
Level 4
Fully integrated and aligned incentives
Full data visibility for current device / equipment analysis and future demand planning across IDN. Recommendations to the IDN for adoption of tech to drive growth, efficiency & outcomes.
Level 3
Cross functional understanding of stakeholder needs and requirements. Clinical integration across company divisions
Fragmented visibility of device/ equipment analysis data for future planning across IDN to drive growth, efficiency and outcomes.
Level 2
Common language and communications
Technology is internal focused but there may be applications to support a more strategic approach (e.g., some quality data) to improve provider efficiency and suggest growth opportunities.
Level 1
Beginning the Conversation
No visibility to device/ equipment analysis data for medium to long term planning across IDN to drive growth and efficiency. No usage of market scan reports for growth opportunity suggestions.
Phone
This field is for validation purposes and should be left unchanged.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
OK
Privacy Policy
